A citation-based method for searching scientific literature

Fateen Ata, Zohaib Yousaf, Adeel Ahmad Khan, Almurtada Razok, Jaweria Akram, Elrazi Awadelkarim Hamid Ali, Ahmed Abdalhadi, Diaeldin Abdelgalil Ibrahim, Dabia Hamad S H Al Mohanadi, Mohammed I Danjuma. Sci Rep 2021
Times Cited: 10







List of co-cited articles
31 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
50

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch. Diabetes Care 2015
456
40

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
40

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
40


Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers.
Manoj R Somagutta, Kuchalambal Agadi, Namrata Hange, Molly S Jain, Erkan Batti, Bernard O Emuze, Elizabeth O Amos-Arowoshegbe, Sorin Popescu, Saad Hanan, Varadha Retna Kumar,[...]. Cureus 2021
7
42

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
Stefan D Anker, Javed Butler, Gerasimos Filippatos, João P Ferreira, Edimar Bocchi, Michael Böhm, Hans-Peter Brunner-La Rocca, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure-Valenzuela,[...]. N Engl J Med 2021
449
30

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
30

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
30

Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report.
Masafumi Fukuda, Masakazu Nabeta, Takanori Muta, Kei Fukami, Osamu Takasu. Int J Emerg Med 2020
6
33


Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin.
Daniel A Kelmenson, Kelsey Burr, Yusra Azhar, Paul Reynolds, Chelsea A Baker, Neda Rasouli. J Investig Med High Impact Case Rep 2017
20
20

Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis.
Mohammed Faraz Rafey, Arslan Butt, Barry Coffey, Lisa Reddington, Aiden Devitt, David Lappin, Francis M Finucane. Endocrinol Diabetes Metab Case Rep 2019
14
20


Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin.
Shreya Pujara, Adriana Ioachimescu. J Investig Med High Impact Case Rep 2017
20
20

Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin.
Junichiro Adachi, Yuusuke Inaba, Chisato Maki. Intern Med 2017
15
20

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
Zien Zhou, Meg J Jardine, Qiang Li, Brendon L Neuen, Christopher P Cannon, Dick de Zeeuw, Robert Edwards, Adeera Levin, Kenneth W Mahaffey, Vlado Perkovic,[...]. Stroke 2021
19
20

Euglycemic diabetic ketoacidosis.
Leonid Barski, Tamar Eshkoli, Evgenia Brandstaetter, Alan Jotkowitz. Eur J Intern Med 2019
42
20

SGLT2 Inhibitors May Predispose to Ketoacidosis.
Simeon I Taylor, Jenny E Blau, Kristina I Rother. J Clin Endocrinol Metab 2015
295
20



Dapagliflozin in Patients with Chronic Kidney Disease.
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, Glenn M Chertow, Tom Greene, Fan-Fan Hou, Johannes F E Mann, John J V McMurray, Magnus Lindberg, Peter Rossing,[...]. N Engl J Med 2020
947
20

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice.
Megumi Oshima, Meg J Jardine, Rajiv Agarwal, George Bakris, Christopher P Cannon, David M Charytan, Dick de Zeeuw, Robert Edwards, Tom Greene, Adeera Levin,[...]. Kidney Int 2021
32
20

SGLT2-I in the Hospital Setting: Diabetic Ketoacidosis and Other Benefits and Concerns.
Joshua A Levine, Susan L Karam, Grazia Aleppo. Curr Diab Rep 2017
15
20

Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
Caroline Bonner, Julie Kerr-Conte, Valéry Gmyr, Gurvan Queniat, Ericka Moerman, Julien Thévenet, Cédric Beaucamps, Nathalie Delalleau, Iuliana Popescu, Willy J Malaisse,[...]. Nat Med 2015
413
20





Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
20

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado,[...]. Lancet 2019
20

An enigmatic triad of acute pancreatitis, diabetic ketoacidosis and hypertriglyceridaemia: who is the culprit?
Umasankar Mathuram Thiyagarajan, Amirthavarshini Ponnuswamy, Alex Chung. BMJ Case Rep 2019
8
12


Plasma Exchange for the Treatment of Transient Extreme Hypertriglyceridemia Associated with Diabetic Ketoacidosis and Acute Pancreatitis.
Davide Donelli, Lorenzo Morini, Chiara Trenti, Rosaria Santi, Dimitriy Arioli, Emanuele Alberto Negri. Eur J Case Rep Intern Med 2018
3
33


Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
Wylie C Hembree, Peggy T Cohen-Kettenis, Louis Gooren, Sabine E Hannema, Walter J Meyer, M Hassan Murad, Stephen M Rosenthal, Joshua D Safer, Vin Tangpricha, Guy G T'Sjoen. J Clin Endocrinol Metab 2017
700
10


Diabetic Ketoacidosis and the Domino Effect.
Bilal H Shaikh, Muneebah Sohaib, Raeda Alshantti, Francisco Barrera, Farah S Faridi, Natia Murvelashvili. Am J Case Rep 2018
2
50

Hypertriglyceridemia-induced pancreatitis: updated review of current treatment and preventive strategies.
Prashanth Rawla, Tagore Sunkara, Krishna Chaitanya Thandra, Vinaya Gaduputi. Clin J Gastroenterol 2018
52
10


Canagliflozin-induced pancreatitis: a rare side effect of a new drug.
Mudit Chowdhary, Ahmad A Kabbani, Akansha Chhabra. Ther Clin Risk Manag 2015
16
10

New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation.
Helen H Wang, Min Liu, Deborah J Clegg, Piero Portincasa, David Q-H Wang. Biochim Biophys Acta 2009
71
10

A Rare Cause of Acute Pancreatitis in a Transgender Female.
Lindsey C Shipley, David T Steele, Charles M Wilcox, Chad M Burski. J Investig Med High Impact Case Rep 2020
3
33

Changes in Size and Demographic Composition of Transgender and Gender Non-Binary Population Receiving Care at Integrated Health Systems.
Qi Zhang, Willi Rechler, Andrew Bradlyn, W Dana Flanders, Darios Getahun, Timothy L Lash, Courtney McCracken, Rebecca Nash, Leonidas Panagiotakopoulos, Douglas Roblin,[...]. Endocr Pract 2021
3
33

Estrogen-induced gallstone pancreatitis in a transgender female.
Emily Freier, Lynn Kassel, Joel Rand, Bhavana Chinnakotla. Am J Health Syst Pharm 2021
1
100

Estrogen-induced severe acute pancreatitis in a male.
Elisa Perego, Alberto Scaini, Fabrizio Romano, Claudio Franciosi, Franco Uggeri. JOP 2004
16
10


Quiz: Metabolic Acidosis in a Patient With Type 2 Diabetes.
Jatinder Kohli, Stanley Goldfarb. Am J Kidney Dis 2017
3
33

Prolonged diabetic ketoacidosis associated with canagliflozin.
Gordon Sloan, Tania Kakoudaki, Nishant Ranjan. Endocrinol Diabetes Metab Case Rep 2018
6
16

Recurrent euglycemic diabetic ketoacidosis after discontinuation of sodium-glucose cotransporter 2 inhibitor.
Spyridoula Maraka, Ann E Kearns, Nana Esi N Kittah, Derek T O'Keeffe. Diabetes Res Clin Pract 2016
9
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.